澳门大阳城122.ccapp官方下载

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes

J. Allergy Clin. Immunol.. 2017-09; 
KaustioMeri, HaapaniemiEmma, GöösHelka, HautalaTimo, ParkGiljun, SyrjänenJaana, EinarsdottirElisabet, SahuBiswajyoti, KilpinenSanna, RouniojaSamuli, FogartyChristopher L, GlumoffVirpi, KulmalaPetri, KatayamaShintaro, TameneFitsum, TrottaLuca, MorgunovaEkaterina, KrjutškovKaarel, NurmiKatariina, EklundKari, LagerstedtAnssi, HelminenMerja, MarteliusTimi, MustjokiSatu, TaipaleJussi, SaarelaJanna, KereJuha, VarjosaloMarkku, SeppänenM
Products/Services Used Details Operation
Gene Synthesis … Generation of mutation constructs and cell lines. The wild-type (WT), H67R, and I553M mutant NFKB1 full-length coding sequences were commercially cloned into a Gateway-compatible entry-vector (GenScript, Piscataway, NJ) … Get A Quote

摘要

The nuclear factor κ light-chain enhancer of activated B cells (NF-κB) signaling pathway is a key regulator of immune responses. Accordingly, mutations in several NF-κB pathway genes cause immunodeficiency.

关键词

B cell,Behçet disease,NFKB1,Nuclear factor κ light-chain enhancer of activated B cells,autoinflammation,hypogammaglobulinemia,p105